[1]
“The characterization of oxaliplatin-induced peripheral neuropathy using electromyography in gastrointestinal cancer patients”, J Curr Biomed Rep, vol. 3, no. 2, pp. 77–83, Jun. 2022, doi: 10.52547/JCBioR.3.2.77.